AIRLINK 73.85 Decreased By ▼ -0.15 (-0.2%)
BOP 5.00 Decreased By ▼ -0.02 (-0.4%)
CNERGY 4.49 Increased By ▲ 0.07 (1.58%)
DFML 40.10 Increased By ▲ 0.90 (2.3%)
DGKC 86.52 Increased By ▲ 0.43 (0.5%)
FCCL 21.73 Increased By ▲ 0.08 (0.37%)
FFBL 34.34 Increased By ▲ 0.33 (0.97%)
FFL 9.90 Decreased By ▼ -0.02 (-0.2%)
GGL 10.72 Increased By ▲ 0.16 (1.52%)
HBL 114.19 Increased By ▲ 0.30 (0.26%)
HUBC 135.99 Increased By ▲ 0.15 (0.11%)
HUMNL 11.90 No Change ▼ 0.00 (0%)
KEL 4.86 Increased By ▲ 0.02 (0.41%)
KOSM 4.55 Increased By ▲ 0.02 (0.44%)
MLCF 38.59 Increased By ▲ 0.32 (0.84%)
OGDC 134.98 Increased By ▲ 0.13 (0.1%)
PAEL 26.52 Increased By ▲ 0.17 (0.65%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.80 Increased By ▲ 0.12 (1.8%)
PPL 122.60 Decreased By ▼ -0.40 (-0.33%)
PRL 27.55 Increased By ▲ 0.86 (3.22%)
PTC 14.20 Decreased By ▼ -0.13 (-0.91%)
SEARL 59.00 Decreased By ▼ -0.12 (-0.2%)
SNGP 68.63 Decreased By ▼ -0.87 (-1.25%)
SSGC 10.36 Increased By ▲ 0.03 (0.29%)
TELE 8.53 Increased By ▲ 0.03 (0.35%)
TPLP 11.20 Decreased By ▼ -0.03 (-0.27%)
TRG 64.78 Decreased By ▼ -0.07 (-0.11%)
UNITY 26.30 Increased By ▲ 0.05 (0.19%)
WTL 1.34 No Change ▼ 0.00 (0%)
BR100 7,861 Increased By 10.8 (0.14%)
BR30 25,339 Increased By 2.6 (0.01%)
KSE100 75,333 Increased By 125.8 (0.17%)
KSE30 24,177 Increased By 34.6 (0.14%)

reckitt LONDON: Consumer goods group Reckitt Benckiser said like-for-like revenue grew 5 percent in the third quarter, underpinned by a strong performance in emerging markets and better trading in North America and Europe.

 

The British maker of Finish dishwasher tablets, Nurofen painkillers and Cillit Bang cleaners, said the results positioned it well to meet its 2012 goals, with market growth now expected to be at the top end of a 1 to 2 percent range.

 

The company is targeting underlying sales growth 200 basis points ahead of the market, i.e a 3 to 4 percent increase, with margins held steady.

 

It said on Wednesday that like-for-like sales, both including and excluding its pharmaceuticals unit, grew by 5 percent in the quarter.

 

That was better than analysts were expecting after the group saw a slowdown in Southern Europe earlier in the year.

 

Analysts at Investec were expecting organic sales growth excluding pharmaceuticals of 3.1 percent, lower than the median analyst consensus of 3.8 percent.

 

Copyright Reuters, 2012

Comments

Comments are closed.